+
Rosatom increasing Russian isotope supplies to India
ECONOMY & POLICY

Rosatom increasing Russian isotope supplies to India

Isotope - Regional Alliance JSC (a Rusatom Healthcare company) delivered the first shipment of germanium-68/gallium-68 (Ge-68/Ga-68) generators manufactured by Cyclotron CJSC (Obninsk) under the new contract with Esente Healthcare, a local medical product distributor, to the Republic of India.

According to the contract terms, Isotope JSC will supply the Indian side with 40 units of Ge-68/Ga-68 generators within a year. Previously, with the assistance of Isotope JSC, a registration certificate was obtained from the Central Drugs Standard Control Organization for the commercialisation of Ge-68/Ga-68 generators from the Russian manufacturer.

Ga-68 isotope is used in nuclear medicine to diagnose a wide range of oncological diseases using PET scanners, allowing performing more than 100,000 diagnostic procedures per year globally.

Anton Shargin, Deputy Director General for Commercial Affairs, Isotope JSC said, "The supply of germanium-68/gallium-68 generators under a contract with the distributor – Esente Healthcare – opens up new opportunities for expansion of the Rosatom State Atomic Energy Corporation presence in the Indian nuclear medicine market and will also ensure the growth of trade in isotope products between our countries”.

Isotope - Regional Alliance JSC (a Rusatom Healthcare company) delivered the first shipment of germanium-68/gallium-68 (Ge-68/Ga-68) generators manufactured by Cyclotron CJSC (Obninsk) under the new contract with Esente Healthcare, a local medical product distributor, to the Republic of India.According to the contract terms, Isotope JSC will supply the Indian side with 40 units of Ge-68/Ga-68 generators within a year. Previously, with the assistance of Isotope JSC, a registration certificate was obtained from the Central Drugs Standard Control Organization for the commercialisation of Ge-68/Ga-68 generators from the Russian manufacturer.Ga-68 isotope is used in nuclear medicine to diagnose a wide range of oncological diseases using PET scanners, allowing performing more than 100,000 diagnostic procedures per year globally.Anton Shargin, Deputy Director General for Commercial Affairs, Isotope JSC said, The supply of germanium-68/gallium-68 generators under a contract with the distributor – Esente Healthcare – opens up new opportunities for expansion of the Rosatom State Atomic Energy Corporation presence in the Indian nuclear medicine market and will also ensure the growth of trade in isotope products between our countries”.

Next Story
Infrastructure Transport

Lucknow Metro East-West Corridor Consultancy Contract Awarded

The Uttar Pradesh Metro Rail Corporation has awarded the first construction-related consultancy contract for the Lucknow Metro East West Corridor to a joint venture of AYESA Ingenieria Arquitectura SAU and AYESA India Pvt Ltd. The firm was declared the lowest bidder for the Detailed Design Consultant contract for Lucknow Metro Line-2 under Phase 1B and the contract was recommended following the financial bid. The contract is valued at Rs 159.0 million (mn), covering design services for the corridor. Lucknow Metro Line-2 envisages the construction of an 11.165 kilometre corridor connecting Cha..

Next Story
Infrastructure Urban

Div Com Kashmir Urges Fast Tracking Of Jhelum Water Transport Project

The Divisional Commissioner of Kashmir has called for the fast-tracking of the Jhelum water transport project, urging district administrations and relevant agencies to accelerate planning and clearances. In a meeting convened at the divisional headquarters, the commissioner instructed officials from irrigation, public health engineering and municipal departments to prioritise the project and coordinate survey and design work. The directive emphasised removal of administrative bottlenecks and close monitoring to ensure timely mobilisation of resources and contractors. Officials were told to in..

Next Story
Infrastructure Urban

Interarch Reports Strong Q3 And Nine Month Results

Interarch Building Solutions Limited reported unaudited results for the third quarter and nine months ended 31 December 2025, recording strong revenue growth driven by execution and a robust order book. Net revenue for the third quarter rose by 43.7 per cent to Rs 5.225 billion (bn), compared with Rs 3.636 bn a year earlier, reflecting heightened demand in pre-engineered building projects. The company’s total order book as at 31 January 2026 stood at Rs 16.85 bn, supporting near-term visibility. EBITDA excluding other income for the quarter increased by 43.2 per cent to Rs 503 million (mn),..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Open In App